204 related articles for article (PubMed ID: 23278588)
21. Trans-synaptic homeostasis at the myasthenic neuromuscular junction.
Plomp JJ
Front Biosci (Landmark Ed); 2017 Mar; 22(7):1033-1051. PubMed ID: 28199191
[TBL] [Abstract][Full Text] [Related]
22. Muscle-specific kinase myasthenia gravis IgG4 autoantibodies cause severe neuromuscular junction dysfunction in mice.
Klooster R; Plomp JJ; Huijbers MG; Niks EH; Straasheijm KR; Detmers FJ; Hermans PW; Sleijpen K; Verrips A; Losen M; Martinez-Martinez P; De Baets MH; van der Maarel SM; Verschuuren JJ
Brain; 2012 Apr; 135(Pt 4):1081-101. PubMed ID: 22396395
[TBL] [Abstract][Full Text] [Related]
23. Absence of decremental response in decentralized muscles of a myasthenic patient.
Fiacchino F; Crenna P; Sghirlanzoni A; Peluchetti D; Allegranza A
Ital J Neurol Sci; 1983 Sep; 4(3):355-7. PubMed ID: 6315636
[TBL] [Abstract][Full Text] [Related]
24. Nature and Action of Antibodies in Myasthenia Gravis.
Ruff RL; Lisak RP
Neurol Clin; 2018 May; 36(2):275-291. PubMed ID: 29655450
[TBL] [Abstract][Full Text] [Related]
25. Electrophysiological analysis of neuromuscular synaptic function in myasthenia gravis patients and animal models.
Plomp JJ; Morsch M; Phillips WD; Verschuuren JJ
Exp Neurol; 2015 Aug; 270():41-54. PubMed ID: 25620417
[TBL] [Abstract][Full Text] [Related]
26. Immunopathology of myasthenia gravis.
Drachman DB
Fed Proc; 1979 Nov; 38(12):2613-5. PubMed ID: 227751
[No Abstract] [Full Text] [Related]
27. Measurement of junctional acetylcholine receptors in myasthenia gravis: clinical correlates.
Pestronk A; Drachman DB; Self SG
Muscle Nerve; 1985; 8(3):245-51. PubMed ID: 4058469
[TBL] [Abstract][Full Text] [Related]
28. Pathological mechanisms in experimental autoimmune myasthenia gravis. II. Passive transfer of experimental autoimmune myasthenia gravis in rats with anti-acetylcholine recepotr antibodies.
Lindstrom JM; Engel AG; Seybold ME; Lennon VA; Lambert EH
J Exp Med; 1976 Sep; 144(3):739-53. PubMed ID: 182897
[TBL] [Abstract][Full Text] [Related]
29. Myasthenia gravis: a personal view of pathogenesis and mechanism, part 2.
Simpson JA
Muscle Nerve; 1978; 1(2):151-6. PubMed ID: 220530
[TBL] [Abstract][Full Text] [Related]
30. How the autoimmune response to acetylcholine receptor impairs neuromuscular transmission in myasthenia gravis and its animal model.
Lindstrom J
Fed Proc; 1978 Dec; 37(14):2828-30. PubMed ID: 214352
[No Abstract] [Full Text] [Related]
31. An electrophysiological and morphological study of the neuromuscular junction in patients with myasthenia gravis.
Albuquerque EX; Rash JE; Mayer RF; Satterfield JR
Exp Neurol; 1976 Jun; 51(3):536-63. PubMed ID: 179836
[No Abstract] [Full Text] [Related]
32. [Myasthenia gravis and other neuromuscular diseases].
Pirskanen R
Duodecim; 1979; 95(21):1401-11. PubMed ID: 527509
[No Abstract] [Full Text] [Related]
33. [Immunologic aspects of disorders of neuromuscular transmission. 2. Experimental autoimmune myasthenia gravis and the Lambert-Eaton myasthenic syndrome].
Andreis I; Lovnićki TJ; Beara N; Taradi M
Lijec Vjesn; 1994; 116(5-6):158-61. PubMed ID: 7968205
[TBL] [Abstract][Full Text] [Related]
34. The emerging diversity of neuromuscular junction disorders.
Newsom-Davis J
Acta Myol; 2007 Jul; 26(1):5-10. PubMed ID: 17915563
[TBL] [Abstract][Full Text] [Related]
35. Increased expression of rapsyn in muscles prevents acetylcholine receptor loss in experimental autoimmune myasthenia gravis.
Losen M; Stassen MH; Martínez-Martínez P; Machiels BM; Duimel H; Frederik P; Veldman H; Wokke JH; Spaans F; Vincent A; De Baets MH
Brain; 2005 Oct; 128(Pt 10):2327-37. PubMed ID: 16150851
[TBL] [Abstract][Full Text] [Related]
36. Ocular myasthenia revisited: insights from pseudo-internuclear ophthalmoplegia.
Khanna S; Liao K; Kaminski HJ; Tomsak RL; Joshi A; Leigh RJ
J Neurol; 2007 Nov; 254(11):1569-74. PubMed ID: 17713827
[TBL] [Abstract][Full Text] [Related]
37. Characterization of neuromuscular synapse function abnormalities in multiple Duchenne muscular dystrophy mouse models.
van der Pijl EM; van Putten M; Niks EH; Verschuuren JJ; Aartsma-Rus A; Plomp JJ
Eur J Neurosci; 2016 Jun; 43(12):1623-35. PubMed ID: 27037492
[TBL] [Abstract][Full Text] [Related]
38. [On the impaired neuromuscular transmission in myasthenia gravis].
Kruckenberg P; Pontzen W; Sandweg R; Bauer H
Z Neurol; 1971; 200(2):158-73. PubMed ID: 4108119
[No Abstract] [Full Text] [Related]
39. Differential susceptibility of the ocular motor system to disease.
Kaminski HJ; Richmonds CR; Kusner LL; Mitsumoto H
Ann N Y Acad Sci; 2002 Apr; 956():42-54. PubMed ID: 11960792
[TBL] [Abstract][Full Text] [Related]
40. Presynaptic function modified by acetylcholine-receptor interaction in experimental autoimmune myasthenia gravis.
Takamori M; Sakato S; Okumura S
J Neurol Sci; 1984; 66(2-3):245-53. PubMed ID: 6099402
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
